Trademark Overview
On Thursday, November 30, 2023, a trademark application was filed for MN with the United States Patent and Trademark Office. The USPTO has given the MN trademark a serial number of 98293587. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, September 26, 2024. This trademark is owned by The Modern Nicotine Company Inc.. The MN trademark is filed in the Pharmaceutical Products, Smoker's Products, Staple Food Products, Advertising, and Business and Retail Services categories with the following description:
chewing gum; non-medicated lozenges;
medicated nasal spray preparations; medicated throat lozenges; medicated throat sprays; nasal and oral spray preparations for use as central nervous system stimulants; nasal spray preparations; nasal sprays for medical purposes; nicotine; nicotine derivatives; nicotine substitutes; gum, patches, oral sprays, transdermal patches, tablets, capsules, lozenges, oral strips, nasal sprays, inhalers, and oral buccal pouches containing nicotine; gum, patches, oral sprays, transdermal patches, tablets, capsules, lozenges, oral strips, nasal sprays, inhalers, and oral buccal pouches containing synthetic nicotine; gum, patches, oral sprays, transdermal patches, tablets, capsules, lozenges, oral strips, nasal sprays, inhalers, and oral buccal pouches containing nicotine derivatives; gum, patches, oral sprays, transdermal patches, tablets, capsules, lozenges, oral strips, nasal sprays, inhalers, and oral buccal pouches containing nicotine substitutes;
online, retail, and wholesale sale of products containing nicotine; online, retail, and wholesale sale of products containing synthetic nicotine; online, retail, and wholesale sale of products containing nicotine derivatives; online, retail, and wholesale sale of products containing nicotine substitutes;
nicotine; synthetic nicotine; nicotine derivatives; nicotine substitutes; gum, patches, oral sprays, transdermal patches, tablets, capsules, lozenges, oral strips, nasal sprays, inhalers, and oral buccal pouches containing nicotine; gum, patches, oral sprays, transdermal patches, tablets, capsules, lozenges, oral strips, nasal sprays, inhalers, and oral buccal pouches containing synthetic nicotine; gum, patches, oral sprays, transdermal patches, tablets, capsules, lozenges, oral strips, nasal sprays, inhalers, and oral buccal pouches containing nicotine derivatives; gum, patches, oral sprays, transdermal patches, tablets, capsules, lozenges, oral strips, nasal sprays, inhalers, and oral buccal pouches containing nicotine substitutes; oral tobacco-derived nicotine pouches as a substitute for snus;
